Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04002401
Title Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Rituximab in Participants With Refractory Large B-Cell Lymphoma
Acronym ZUMA-14
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gilead Sciences
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
City of Hope National Medical Center Duarte California 91010-3012 United States Details
Stanford Cancer Institute Palo Alto California 94305 United States Details
UCLA Hematology/Oncology Santa Monica California 90404 United States Details
Mayo Clinic Florida Jacksonville Florida 32224 United States Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
Loyola University Medical Center Maywood Illinois 60153 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
John Theurer Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Columbia University Medical Center, New York Presbyterian Hospital New York New York 10032 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
St. David's South Austin Medical Center Austin Texas 78704 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Swedish Cancer Institute Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field